Rewriting the Prognosis: Inside the Rapid Evolution of Liver Cancer Drug Market Development
Liver cancer—one of the most aggressive and lethal malignancies worldwide—is experiencing a radical transformation. The days of limited treatment options...
Liver cancer—one of the most aggressive and lethal malignancies worldwide—is experiencing a radical transformation. The days of limited treatment options...
Expression analysis of AFP and GPC3 in liver cancerTo develop effective and safe CAR-T cell therapy for liver cancer, we...
Credit: Hepatology (2025). DOI: 10.1097/HEP.0000000000001406 Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of...
Comparative study process of LLMs and doctors in predicting immune therapy response for liver cancer. Credit: Wang Tengfei, from the...
Credit: Ivan Samkov from Pexels An interdisciplinary research team has demonstrated a durable and lasting response to a novel treatment—combined...
A new ultrasound-based treatment that destroys liver cancer tumours without surgery or radiation will be offered to NHS patients this...